Brokerages Set Foghorn Therapeutics Inc. (NASDAQ:FHTX) Target Price at $13.17
Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have earned a consensus rating of “Buy” from the six analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the […]
Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have earned a consensus rating of “Buy” from the six analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, four have assigned a buy recommendation and one has assigned a strong buy recommendation to the […]
